Oral Biologics & Biosimilar Drugs Market Growth Analysis, Latest Trends – Including Novartis, Rani Therapeutics

Spread the love

The Oral Biologics & Biosimilar Drugs Global Market Report 2021-31 by The Business Research Company describes and explains the global oral biologics & biosimilar drugs market and covers 2016 to 2021, termed the historic period, and 2022 to 2026, termed the forecast period, along with further forecasts for the period 2026-2031. The report evaluates the market across each region and for the major economies within each region.

The Oral Biologics & Biosimilar Drugs Global Market Report 2022 covers oral biologics & biosimilar drugs market drivers, oral biologics & biosimilar drugs market trends, oral biologics & biosimilar drugs market segments, oral biologics & biosimilar drugs market growth rate, oral biologics & biosimilar drugs market major players, and oral biologics & biosimilar drugs market size.

View Complete Report:

https://www.thebusinessresearchcompany.com/report/oral-biologics-and-biosimilar-drug-global-market-report

The oral biologics & biosimilar drugs market report provides in-depth analysis of the impact of COVID-19 on the global oral biologics & biosimilar drugs industry along with revised market numbers due to the effects of the coronavirus and the expected oral biologics & biosimilar drugs market growth numbers for 2022-2031.

The global oral biologics & biosimilar drugs market size is expected to grow from $4.06 billion in 2021 to $4.91 billion in 2022 at a compound annual growth rate (CAGR) of 21%. The growth in the market is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The oral biologics and biosimilar drugs market share is expected to reach $10.41 billion in 2026 at a CAGR of 20.7%.

Request Report Sample Now:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3792&type=smp

Oral Biologics & Biosimilar Drugs Global Market Report 2022 is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 60 geographies. The chapter on the impact of COVID-19 gives valuable insights on supply chain disruptions, logistical challenges, and other economic implications of the virus on the market. The chapter also covers markets which have been positively affected by the pandemic.

TBRC’s report covers the oral biologics & biosimilar drugs market segments-
1) By Therapy: Lymphocyte Modulators, Interleukin Inhibitors, Tumor Necrosis Factor-Alpha Inhibitors

2) By Disease: Asthma, Crohn’s Disease, Carcinoma, Arthritis, Diabetes, Multiple Myeloma, Enterocolitis, Multiple Sclerosis, Sarcoma, Psoriasis and Others

3) By Molecule Type: Vaccines, Proteins & Peptides, Monoclonal Antibodies, Others

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

 

Table Of Contents

1. Executive Summary

2. Oral Biologics & Biosimilars Market Characteristics

3. Oral Biologics & Biosimilars Market Trends And Strategies

4. Impact Of COVID-19 On Oral Biologics & Biosimilars

5. Oral Biologics & Biosimilars Market Size And Growth

28. Oral Biologics & Biosimilars Pipeline Analysis

29. Key Mergers And Acquisitions In The Oral Biologics & Biosimilars Market

30. Oral Biologics & Biosimilars Market Future Outlook and Potential Analysis

31. Appendix

 

List Of Tables

Figure 1: Global Historic Market Growth, 2016-2021, $ Billion

Figure 2: Global Forecast Market Growth, 2021-2026F, 2031F, $ Billion

Figure 3: Global Oral Biologics & Biosimilars Market, Segmentation  By Therapy, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

Figure 4: Global Oral Biologics & Biosimilars Market, Segmentation  By Disease, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

Figure 5: Global Oral Biologics & Biosimilars Market, Segmentation  By Molecule Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

 

Related Reports

Biosimilar Monoclonal Antibodies Global Market Report 2022
Biologics Global Market Report 2022
Biosimilar Hormones Global Market Report 2022

 

About The Business Research Company:
The Business Research Company is a market intelligence firm that excels in company, market, and consumer research. Located globally it has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services, chemicals, and technology. It has offices in the UK, the US and India and a network of trained researchers in 20+ countries globally.

Contact Information:
The Business Research Company
Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293

Email: [email protected]

Find us on

LinkedInhttps://in.linkedin.com/company/the-business-research-company

YouTubehttps://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Twitterhttps://twitter.com/tbrc_info

Facebookhttps://www.facebook.com/TheBusinessResearchCompany/

Bloghttp://blog.tbrc.info/


Spread the love

About Top PR News

TopPRnews Leads Drives Search Engine Visibility For Your Press Release Content. Our Global Network Reaches Important Contacts, Media Partners And Websites And Journalists. Happy Postings! If You Have Any Queries Please Contact Official Mail At [[email protected]}

View all posts by Top PR News →